First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Stock Price Down 2.4% – Time to Sell?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)’s stock price was down 2.4% on Thursday . The stock traded as low as $161.98 and last traded at $162.01. Approximately 13,442 shares traded hands during trading, a decline of 44% from the average daily volume of 24,218 shares. The stock had previously closed at $165.99.

First Trust NYSE Arca Biotechnology Index Fund Trading Down 5.7 %

The company has a market cap of $1.01 billion, a P/E ratio of 24.89 and a beta of 0.70. The business has a 50 day moving average price of $172.84 and a 200-day moving average price of $171.78.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Hedge funds have recently bought and sold shares of the company. Juncture Wealth Strategies LLC increased its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 7.4% in the fourth quarter. Juncture Wealth Strategies LLC now owns 11,318 shares of the company’s stock valued at $1,881,000 after purchasing an additional 777 shares during the last quarter. Daymark Wealth Partners LLC grew its stake in First Trust NYSE Arca Biotechnology Index Fund by 2.7% in the 4th quarter. Daymark Wealth Partners LLC now owns 5,306 shares of the company’s stock valued at $882,000 after buying an additional 141 shares during the last quarter. Park Avenue Securities LLC raised its holdings in First Trust NYSE Arca Biotechnology Index Fund by 10.3% in the 4th quarter. Park Avenue Securities LLC now owns 3,918 shares of the company’s stock valued at $651,000 after acquiring an additional 365 shares during the period. JPMorgan Chase & Co. raised its holdings in First Trust NYSE Arca Biotechnology Index Fund by 25.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 15,945 shares of the company’s stock valued at $2,741,000 after acquiring an additional 3,275 shares during the period. Finally, Financial Enhancement Group LLC boosted its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 32.2% during the fourth quarter. Financial Enhancement Group LLC now owns 4,886 shares of the company’s stock worth $851,000 after acquiring an additional 1,189 shares during the period.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.